Michael Elniski BecomesNew Vice President of ClearFlow Global Sales

UltraSight Raises $13 million to Bring AI Guidance for Cardiac Ultrasound to Patient Point of Care

The Yozma Group Korea, Atain Specialty Insurance Company and the Weizmann Institute of Science participated in the round.

Jon Hopkins New Senior Vice President-Chief Development Officer of Legion Healthcare Partners

Over the past 23 years, Jon has held various positions at Varian Medical Systems including Director of Sales, Americas West & Latin America, Varian Proton Solutions and prior Director of Worldwide Sales, Varian Particle Therapy.

Sinan Batman Appointed CTO of TeraRecon

Batman brings rich industry experience to TeraRecon, including Chief Engineer at Carestream/Kodak Health Group, where he defined the vision for image-centric workflow information systems.

ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales.

Elniski, who most recently served as Franchise VP of Cardiac Critical Care at Merit Medical and was previously VP of Healthcare Solutions at Edwards Lifesciences, is recognized for building sales organizations that consistently over-achieve sales goals. He brings to ClearFlow a rich expertise in developing commercial strategy and execution focused on competitive and disruptive medical device solutions.

“Michael has had a distinguished career to date, with major corporations in his wake, including 16 years at Edwards rising through the ranks from sales professional to executive leadership positions there and at Merit,” said Paul Molloy, CEO of ClearFlow. “His sales and commerce credentials are truly impressive but his work ethic, character and personality are what sealed our attraction to him. Michael is hard working, organized, disciplined and focused and brings years of medical device commercialization experience to ClearFlow. It’s a great fit and we look forward to reaping the benefits of his skills and expertise as we continue to grow and develop a world class sales organization befitting our innovative and disruptive science and technology.”

ClearFlow is the manufacturer of the PleuraFlow® Active Clearance Technology® (ACT®) System – the only FDA cleared device available that enables caregivers to proactively remove clots formed inside the chest tube to prevent or minimize chest tube occlusion with clot. A patent chest tube enables evacuation of blood and fluid from the operative site after closure of the surgical wound and reduces retained blood. Retained blood is accepted by physicians as contributing to many common complications after cardiac surgery, including post-operative atrial fibrillation (POAF), pleural effusions and pericardial effusions. PleuraFlow is used at the bedside in the ICU and enables caregivers to actively maintain chest tube patency following cardiac surgery.

The PleuraFlow ACT System is approved for use in the U.S., Europe, Australia, Brazil, Canada, Mexico and other countries in Asia and the Middle East.



Subscribe to Medical Device News Magazine here.

Related Articles